Loading…
Product type
Niraparib Tosylate is a high-potency active pharmaceutical ingredient (API) primarily used in the treatment of certain types of cancer, particularly ovarian cancer. It functions as a poly (ADP-ribose) polymerase (PARP) inhibitor, which interferes with the cancer cell's ability to repair DNA damage, leading to cell death. This compound is typically synthesized through complex chemical processes that ensure its potency and effectiveness in therapeutic applications.
| Chemical formula | C19H22N4O4S |
| Molecular weight | 398.47 g/mol |
| Purity | Typically ≥ 98% |
| Form | Powder |
| Solubility | Soluble in DMSO and methanol |
When selecting Niraparib Tosylate, buyers should consider the required purity levels, as higher purity is often necessary for pharmaceutical applications. It is also important to specify the quantity needed, as this can affect pricing and availability. Additionally, inquire about any relevant certifications or compliance with regulatory standards for pharmaceutical ingredients, especially if the product will be used in clinical settings.
Get quotes for Niraparib Tosylate
Tell us your requirement — quantity, specs and timeline — and our team sources verified manufacturers and brings you the best quote.
It is primarily used in the treatment of ovarian cancer as a PARP inhibitor.
The typical purity is ≥ 98%.
It is usually supplied in powder form.
Niraparib Tosylate is soluble in DMSO and methanol.
Yes, it is commonly used in clinical trials for cancer treatments.
Check for purity, compliance with regulations, and supplier certifications.